Stephanie Tcherny

Global Head of Benefit-Risk Evaluation - Sanofi

Stephanie, public health physician, has over 17 years of experience working in pharma companies on Pharmacoepidemiology and BR evaluation to support market access, pricing and risk management plans. After her appointments at Eli Lilly, she joined Global Pharmacovigilance & Epidemiology department at Sanofi in 2010 as a Global   Pharmacoepidemiologist, as  a   Pharmacoepidemiology   Lead   in   2016   and Head of Benefit-Risk evaluation in 2017. Stephanie is one of the leading experts in the qualitative and quantitative   BR   field   and   has   conducted   several   benefit-risk   analyses   for development and marketed drugs for over 10 years.

Stephanie Tcherny

 Download Presentation

Stay Informed

Subscribe today to receive news on latest updates,
offers and upcoming conferences via email

For general conference and registration enquires please contact the below email id or fill out the form

Enquire now